TY - JOUR
T1 - Relationship between dyslipidemia and albuminuria in hypertensive adults a nationwide population-based study
AU - Lee, Sung Ho
AU - Kim, Do Hoon
AU - Kim, Yang Hyun
AU - Roh, Yong Kyun
AU - Ju, Sang Yhun
AU - Nam, Hyo Yun
AU - Nam, Ga Eun
AU - Choi, Jun Seok
AU - Lee, Jong Eun
AU - Sang, Jung Eun
AU - Han, Kyungdo
AU - Park, Yong Gyu
N1 - Publisher Copyright:
© 2016 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2016
Y1 - 2016
N2 - This study aimed to estimate the relationship between various lipid abnormalities and albuminuria in hypertensive Korean adults. Data obtained from the Korea National Health and Nutrition Examination Survey in 2011 to 2012 were analyzed. The study included 2330 hypertensive participants. Total cholesterol (TC), triglyceride (TG), highdensity lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) levelsweremeasured.Dyslipidemia parameterswere defined as high TG≥200mg/dL, lowHDL-CasHDL-C<40mg/dL, high TC/HDL-C as TC/HDL-C ratio ≥4, high TG/HDL-C as TG/HDL-C ratio ≥3.8, and high LDL-C/HDL-C as LDL-C/HDL-C ratio ≥2.5. Albuminuria was defined as a urine albumin to creatinine ratio (ACR) ≥30mg/g. Women with albuminuria showed significantly higher levels of TG, TC/HDL-C, and TG/HDL-C and a lower level ofHDL-C thanwomenwithout albuminuria (all P<0.05). LogTG, TC/HDL-C, and logTG/HDL-C were positively correlatedwithACRin bothmen andwomen; however,HDL-C was negatively correlated with ACR in women and non-HDL-C was positively correlated with ACR in men. In men, there was no association betweenACRand lipid parameters.However, inwomen, higher values for logTG, TC/HDL-C, and logTG/HDL-Cwere associatedwith an increased odds ratio (OR) for albuminuria (OR [95% confidence interval]: 1.53 [1.06-2.21], 1.21 [1.02-1.45], and 1.78 [1.21-2.63], respectively) and HDL-C with a decreased OR for albuminuria (0.78 [0.67-0.92]) after adjusting for all covariates. LogTG, TC/HDL-C, and logTG/HDL-C were associated with an increased prevalence of albuminuria in hypertensive women. Screening and treatment for dyslipidemia may be necessary for hypertensive women to address potential albuminuria.
AB - This study aimed to estimate the relationship between various lipid abnormalities and albuminuria in hypertensive Korean adults. Data obtained from the Korea National Health and Nutrition Examination Survey in 2011 to 2012 were analyzed. The study included 2330 hypertensive participants. Total cholesterol (TC), triglyceride (TG), highdensity lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) levelsweremeasured.Dyslipidemia parameterswere defined as high TG≥200mg/dL, lowHDL-CasHDL-C<40mg/dL, high TC/HDL-C as TC/HDL-C ratio ≥4, high TG/HDL-C as TG/HDL-C ratio ≥3.8, and high LDL-C/HDL-C as LDL-C/HDL-C ratio ≥2.5. Albuminuria was defined as a urine albumin to creatinine ratio (ACR) ≥30mg/g. Women with albuminuria showed significantly higher levels of TG, TC/HDL-C, and TG/HDL-C and a lower level ofHDL-C thanwomenwithout albuminuria (all P<0.05). LogTG, TC/HDL-C, and logTG/HDL-C were positively correlatedwithACRin bothmen andwomen; however,HDL-C was negatively correlated with ACR in women and non-HDL-C was positively correlated with ACR in men. In men, there was no association betweenACRand lipid parameters.However, inwomen, higher values for logTG, TC/HDL-C, and logTG/HDL-Cwere associatedwith an increased odds ratio (OR) for albuminuria (OR [95% confidence interval]: 1.53 [1.06-2.21], 1.21 [1.02-1.45], and 1.78 [1.21-2.63], respectively) and HDL-C with a decreased OR for albuminuria (0.78 [0.67-0.92]) after adjusting for all covariates. LogTG, TC/HDL-C, and logTG/HDL-C were associated with an increased prevalence of albuminuria in hypertensive women. Screening and treatment for dyslipidemia may be necessary for hypertensive women to address potential albuminuria.
UR - http://www.scopus.com/inward/record.url?scp=84966297404&partnerID=8YFLogxK
U2 - 10.1097/MD.0000000000003224
DO - 10.1097/MD.0000000000003224
M3 - Article
C2 - 27100412
AN - SCOPUS:84966297404
SN - 0025-7974
VL - 95
JO - Medicine (United States)
JF - Medicine (United States)
IS - 16
M1 - e3224
ER -